Status:
UNKNOWN
Attention Retraining for Anxiety Disorder Patients Resistent to Antidepressants
Lead Sponsor:
Hospital de Clinicas de Porto Alegre
Conditions:
Generalized Anxiety Disorder
Social Anxiety Disorder
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The objective of this project is to test the combination of active or placebo Attentional Bias Modification Treatment (ABMT) to usual treatment for anxiety disorder patients resistant to antidepressan...
Eligibility Criteria
Inclusion
- Primary diagnosis of Generalized Anxiety Disorder, Panic Disorder or Social Anxiety Disorder according to the International Neuropsychiatric Interview psychiatric interview (M.I.N.I.)
- Current treatment for the anxiety disorder with antidepressants with an appropriate dose for at least 8 weeks;
- Score on OASIS (Overall Anxiety Severity and Impairment Scale)equal or greater than 8
Exclusion
- Other psychiatric disorder that causes more impairment and suffering than generalized anxiety disorder, panic disorder or social anxiety disorder in the clinical evaluation
- Current Cognitive Behavior Therapy
- Marked intellectual disability (clinically evident)
- Suicidal ideation or suicide plan at the time of assessment(M.I.N.I.)
- Psychotic disorder (M.I.N.I.)
- Bipolar disorder type I (M.I.N.I.)
- Abuse / Dependence substances (M.I.N.I.)
Key Trial Info
Start Date :
July 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT01906268
Start Date
July 1 2013
Last Update
July 21 2014
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital de Clínicas de Porto Alegre
Porto Alegre, Rio Grande do Sul, Brazil, 90040-371
2
Hospital de Clínicas de Porto Alegre
Porto Alegre, Rio Grande do Sul, Brazil, 90040-371